Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of epsilon phenotype in brain glucose consumption in Alzheimer's disease.

Annals of nuclear medicine - 1 Apr 2020

Ricci Maria, Chiaravalloti Agostino, Martorana Alessandro, Koch Giacomo, De Lucia Vincenzo, Barbagallo Gaetano, Schillaci Orazio

Abstract excerpt

OBJECTIVE: The aim of our study was to investigate the impact of the epsilon phenotype in brain glucose consumption in a population with Alzheimer's disease. METHODS: Statistical Parametric Mapping (SPM8) was used to investigate differences in brain glucose consumption (as detectable by means of 18F FDG-PET/CT) in the population examined. A total of 129 patients (72 females and 57 males) with a diagnosis of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid
Share to Cerebrospinal Fluid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Education

Share to Fluorodeoxyglucose F18

Share to Mental Status and Dementia Tests

Share to Positron Emission Tomography Computed Tomography

Share to Radiopharmaceuticals

Share to tau Proteins

Source

Identifiers

PMID: 32016694
DOI: 10.1007/s12149-020-01441-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of epsilon phenotype in brain glucose consumption in Alzheimer's disease.PMID 32016694Read ↗

Cerebral glucose metabolism in patients with AD and different APOE genotypes.Semantic proximity Read ↗

Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients.Semantic proximity Read ↗

Lack of association of apolipoprotein E epsilon4 allele dose with cerebral glucose metabolism in Alzheimer disease.Semantic proximity Read ↗

No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes.Semantic proximity Read ↗

Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.Semantic proximity Read ↗

The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset.Semantic proximity Read ↗

Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease.Semantic proximity Read ↗

Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease.Semantic proximity Read ↗

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.Semantic proximity Read ↗

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.Semantic proximity Read ↗

Impaired fasting glucose is associated with increased regional cerebral amyloid.Semantic proximity Read ↗

Progression of cerebral amyloid load is associated with the apolipoprotein E ε4 genotype in Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.